EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improved health by combining dietary restriction and promoting muscle growth in DNA repair‐deficient progeroid mice

Wilbert P Vermeij iD, Khalid Alyodawi, Ivar van Galen, Jennie L von der Heide, María B Birkisdóttir, Lisanne J Van't Sant, Rutger A Ozinga, Daphne S J Komninos, Kimberly Smit, Yvonne M A Rijksen, Renata M C Brandt, Sander Barnhoorn und 6 weitere

Journal of Cachexia, Sarcopenia and Muscle · 2024

DOI: 10.1002/jcsm.13570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2024. Verfasst von Wilbert P Vermeij und 17 weiteren Autor:innen. Beteiligte Einrichtung: Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands. Hauptthemen laut MEDLINE: Caloric Restriction, DNA Repair. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, DFG, BMBF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ageing is a complex multifactorial process, impacting all organs and tissues, with DNA damage accumulation serving as a common underlying cause. To decelerate ageing, various strategies have been applied to model organisms and evaluated for health and lifespan benefits. Dietary restriction (DR, also known as caloric restriction) is a well‐established long‐term intervention recognized for its universal anti‐ageing effects. DR temporarily suppresses growth, and when applied to progeroid DNA repair‐deficient mice doubles lifespan with systemic health benefits. Counterintuitively, attenuation of myostatin/activin signalling by soluble activin receptor (sActRIIB), boosts the growth of muscle and, in these animals, prevents muscle wasting, improves kidney functioning, and compresses morbidity.

Methods

Here, we investigated a combined approach, applying an anabolic regime (sActRIIB) at the same time as DR to Ercc1 Δ/− progeroid mice. Following both single treatments and combined, we monitored global effects on body weight, lifespan and behaviour, and local effects on muscle and tissue weight, muscle morphology and function, and ultrastructural and transcriptomic changes in muscle and kidney.

Results

Lifespan was mostly influenced by DR (extended from approximately 20 to 40 weeks; P < 0.001), with sActRIIB clearly increasing muscle mass (35–65%) and tetanic force ( P < 0.001). The combined regime yielded a stable uniform body weight, but increased compared with DR alone, synergistically improved motor coordination and further delayed the onset and development of balance problems. sActRIIB significantly increased muscle fibre size ( P < 0.05) in mice subjected to DR and lowered all signs of muscle damage. Ercc1 Δ/− mice showed abnormal neuromuscular junctions. Single interventions by sActRIIB treatment or DR only partially rescued this phenotype, while in the double intervention group, the regularly shaped junctional foldings were maintained. In kidney of Ercc1 Δ/− mice, we observed a mild but significant foot process effacement, which was restored by either intervention. Transcriptome analysis also pointed towards reduced levels of DNA damage in muscle and kidney by DR, but not sActRIIB, while these levels retained lower in the double intervention.

Conclusions

In muscle, we found synergistic effects of combining sActRIIB with DR, but not in kidney, with an overall better health in the double intervention group. Crucially, the benefits of each single intervention are not lost when administered in combination, but rather strengthened, even when sActRIIB was applied late in life, opening opportunities for translation to human.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caloric RestrictionDNA RepairAnimalsMiceMuscle, SkeletalProgeriaDNA-Binding ProteinsMice, KnockoutMaleEndonucleasesDisease Models, Animal

Stichwörter der Autor:innen

AgeingDietary restrictionKidneyMuscleMyostatinProgeria

Substanzen

Ercc1 protein, mouseDNA-Binding ProteinsEndonucleases

Autor:innen und Institutionen

  • Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Oncode Institute, Utrecht, Netherlands.
  • School of Biological Sciences, University of Reading, Reading, UK.
  • College of Medicine, Wasit University, Kut, Iraq.
  • III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Hamburg Center for Kidney Health (HCKH), Hamburg, Germany.

ORCID-Profile: Wilbert P Vermeij

Förderung

  • Deutsche Forschungsgemeinschaft
  • DFG
  • BMBF
  • ONCODE by the Dutch Cancer Society
  • Netherlands Organisation for Scientific Research (NWO)
  • Memorabel (ZonMW)
  • ADPS Longevity Research Award
  • Regiodeal Foodvalley

Zitieren

APA

Vermeij, W. P., Alyodawi, K., van Galen, I., von der Heide, J. L., Birkisdóttir, M. B., Van't Sant, L. J., Ozinga, R. A., Komninos, D. S. J., Smit, K., Rijksen, Y. M. A., Brandt, R. M. C., Barnhoorn, S., Jaarsma, D., Vaiyapuri, S., Ritvos, O., Huber, T. B., Kretz, O., & Patel, K. (2024). Improved health by combining dietary restriction and promoting muscle growth in DNA repair‐deficient progeroid mice. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13570

Vancouver

Vermeij WP, Alyodawi K, van Galen I, von der Heide JL, Birkisdóttir MB, Van't Sant LJ, et al. Improved health by combining dietary restriction and promoting muscle growth in DNA repair‐deficient progeroid mice. Journal of Cachexia, Sarcopenia and Muscle. 2024. doi:10.1002/jcsm.13570

BibTeX
@article{Vermeij2024,
  author = {Vermeij, Wilbert P and Alyodawi, Khalid and van Galen, Ivar and von der Heide, Jennie L and Birkisdóttir, María B and Van't Sant, Lisanne J and Ozinga, Rutger A and Komninos, Daphne S J and Smit, Kimberly and Rijksen, Yvonne M A and Brandt, Renata M C and Barnhoorn, Sander and Jaarsma, Dick and Vaiyapuri, Sathivel and Ritvos, Olli and Huber, Tobias B and Kretz, Oliver and Patel, Ketan},
  title = {Improved health by combining dietary restriction and promoting muscle growth in DNA repair‐deficient progeroid mice},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2024},
  doi = {10.1002/jcsm.13570}
}
Kostenlos starten →